# Eli Lilly and Company (LLY) — Q4-2011 Earnings Results

**Report date:** 2012-01-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2011

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.87 | N/A | +7.81% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth. They are focused on their product pipeline and maintaining market position.

**Key quotes:**

> Management highlighted the ongoing focus on innovation and pipeline development.

> They emphasized the importance of maintaining strong relationships with healthcare providers.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about the company's future performance. The stock reaction is currently unavailable, which adds to the ambiguity surrounding investor sentiment following the report.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2011_